The inhibitory effect of PACAP38 on ovulation is mediated by CRF and endogenous opioids.
Kántor
O
O
Department of Human Morphology and Developmental Biology, Semmelweis University, Faculty of Medicine, Budapest, Hungary. kantor@ana2.sote.hu
Molnár
J
J
Heinzelmann
A
A
Fürst
Z
Z
Arimura
A
A
Köves
K
K
D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology / Q000502:physiology*; D005260:Female; D007031:Hypothalamus / Q000187:drug effects / Q000502:physiology; D007276:Injections, Intraventricular; D007986:Luteinizing Hormone / Q000378:metabolism; D008550:Melatonin / Q000494:pharmacology; D008954:Models, Biological; D009270:Naloxone / Q000494:pharmacology; D009479:Neuropeptides / Q000008:administration & dosage / Q000494:pharmacology*; D018847:Opioid Peptides / Q000502:physiology*; D010060:Ovulation / Q000187:drug effects* / Q000502:physiology*; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D010902:Pituitary Gland / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013004:Somatostatin / Q000494:pharmacology
C495403:Adcyap1 protein, rat; D009479:Neuropeptides; D018847:Opioid Peptides; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D009270:Naloxone; D013004:Somatostatin; D007986:Luteinizing Hormone; D003346:Corticotropin-Releasing Hormone; D008550:Melatonin